beta Amyloid 1-16 antibody
Quick Overview for beta Amyloid 1-16 antibody (ABIN2961825)
Target
Reactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Specificity
- Reacts with humanand mouse Aβ1-16 as well as other Aβ peptides: Aβ37, Aβ38, Aβ39, Aβ40 and Aβ42
-
Purification
- Purified
-
Immunogen
- Synthetic peptide corresponding to Abeta1-16.
-
Isotype
- IgG1
-
-
-
-
Application Notes
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only:
1 - 10 μg/mL for any applications -
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS, pH 7.4.
-
Handling Advice
- Dilute in PBS or medium which is identical to that used in the assay system.
-
Storage
- -20 °C
-
Storage Comment
- Stable for at least one year at -20°C
-
Expiry Date
- 12 months
-
-
- beta Amyloid 1-16
-
Alternative Name
- Amyloid beta 1-16
-
Background
-
Accumulation and aggregation of amyloid β (Aβ) in the brain is indicated as the trigger of a pathological cascade that causes Alzheimer disease (AD). There is now compelling evidence that metal binding to Aβ is involved in AD pathogenesis. The amino acid region 1-16 is widely considered as the metal binding domain of Aβ. Unlike copper(II) that prefers the N-terminal amino group as the main binding site, zinc(II) is preferentially placed in the 8-16 amino acidic region of Aβ (1-16).
Amyloid beta A4 protein ABPP APPI, APP Alzheimer disease amyloid protein Cerebral vascular amyloid peptide, CVAP PreA4 Protease nexin-II, PN-II Gene name: APP, A4, AD1 -
Gene ID
- 351
-
UniProt
- P05067
Target
-